![Esther Rajavelu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Esther Rajavelu
Algemeen Directeur bij
SPERO THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-07-2026
Profiel
Esther Rajavelu is currently President, CEO, CFO, Treasurer & Director at Spero Therapeutics, Inc. since 2025.
Former positions include Chief Financial Officer & Treasurer at Fulcrum Therapeutics, Inc. from 2022 to 2023; Senior Equities Research Analyst at UBS Securities LLC from 2020 to 2022; Executive Director & Senior Analyst at Oppenheimer & Co., Inc. (Broker) from 2018 to 2020; Research Analyst at Deutsche Bank Securities, Inc. from 2014 to 2018; Vice President-Life Sciences at Ernst & Young Capital Advisors LLC from 2011 to 2014; Vice President at Merrill Lynch, Pierce, Fenner & Smith, Inc.; Analyst at J.P.
Morgan & Co., Inc. (Old); Associate at Towers Perrin Capital Markets, Inc. Education includes undergraduate degree from Wesleyan University and MBA from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-05-2026 | 986.851 ( 1,7% ) | 1 M $ | 31-07-2026 |
Actieve functies van Esther Rajavelu
| Bedrijven | Functie | Begin |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Algemeen Directeur | 10-01-2025 |
Eerdere bekende functies van Esther Rajavelu
| Bedrijven | Functie | Einde |
|---|---|---|
| FULCRUM THERAPEUTICS, INC. | Financieel Directeur/CFO | 21-04-2023 |
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-01-2022 |
Oppenheimer & Co., Inc. (Broker)
 Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-01-2020 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-06-2018 |
Ernst & Young Capital Advisors LLC
 Ernst & Young Capital Advisors LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01-01-2014 |
Opleiding van Esther Rajavelu
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
11
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Towers Perrin Capital Markets, Inc. | |
J.P. Morgan & Co., Inc. (Old)
 J.P. Morgan & Co., Inc. (Old) Regional BanksFinance Provides commercial banking and investment advisory services | Finance |
Oppenheimer & Co., Inc. (Broker)
Oppenheimer & Co., Inc. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrill Lynch, Pierce, Fenner & Smith, Inc.
 Merrill Lynch, Pierce, Fenner & Smith, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Ernst & Young Capital Advisors LLC
Ernst & Young Capital Advisors LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fulcrum Therapeutics, Inc.
 Fulcrum Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for patients by transforming gene regulation in disease | Health Technology |
